Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis
United European Gastroenterology Journal · 2025
DOI: 10.1002/ueg2.12643 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Benedikt Silvester Hofer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Hypertension, Portal, Inflammation, Liver Cirrhosis, Alcoholic, Liver Cirrhosis, Experimental. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Austrian Federal Ministry for Digital and Economic Affairs, the National Foundation for Research, Technology and Development, the Christian Doppler Research As…, Bundesministerium für Digitalisierung und Wirtschaftsstandort, Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung.
Abstract (Originalsprache)
Background
Portal hypertension (PH) resulting from static and dynamic intrahepatic changes drives liver‐related complications even after removing the underlying aetiological factor.
Objective
We investigated the impact of inflammation on the dynamic component of PH during disease regression in animal models of toxin‐induced cirrhosis and patients with alcohol‐related cirrhosis.
Methods
In mice, cirrhosis was induced via toxin application for 12 weeks followed by toxin‐withdrawal allowing for one or 2 weeks of regression. Furthermore, 128 patients with alcohol‐related cirrhosis and alcohol abstinence undergoing same‐day hepatic venous pressure gradient (HVPG) and liver stiffness measurement (LSM) were included. The influence of inflammation on the dynamic PH component was assessed using linear models. Specifically, we explored proinflammatory changes in mice/patients in whom the measured portal pressure (PP)/HVPG was significantly higher than the PP/HVPG expected from the static PH component (histological collagen proportionate area [CPA; %] in mice, LSM in patients).
Results
In mice, toxin discontinuation induced a significant decrease in PP, CPA, histological hepatic inflammation and hepatic expression of proinflammatory genes ( Tnfa , Il6 , Cxcl1 , Mcp1 ; all p < 0.05 for one/2 week regression vs. peak disease). Similarly, prolonged abstinence in alcohol‐related cirrhosis was linked to lower HVPG/LSM and longer abstinence was correlated to lower C‐reactive protein (CRP), IL‐6, immunoglobulin A (IgA) and IgG levels (all p < 0.05). Nevertheless, the persistence of a low‐grade proinflammatory state during regression was linked to a higher PP/HVPG than expected from static PH components. In regressive mice, higher hepatic proinflammatory gene expression ( Tnfa , Il6 , Il1b ; all p < 0.05) was linked to higher‐than‐expected PP. Similarly, higher CRP, IL‐6, IgA and IgG and lower complement factor C3c (all p < 0.05) were associated with higher‐than‐expected HVPG in abstinent patients with alcohol‐related cirrhosis.
Conclusions
Although removing the underlying aetiological factor resulted in significant improvements, a persistent hepatic proinflammatory environment remained a key driver of the dynamic PH component in regressive liver disease. Clinical trial number NCT03267615.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- Vienna Hepatic Haemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
- Christian Doppler Lab for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.
- Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria.
- Institute of Pathology, Medical University of Graz, Graz, Austria.
ORCID-Profile: Benedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer, Vlad Taru, Georg Semmler, Mattias Mandorfer, Thomas Reiberger
Förderung
- Austrian Federal Ministry for Digital and Economic Affairs, the National Foundation for Research, Technology and Development, the Christian Doppler Research As…
- Bundesministerium für Digitalisierung und Wirtschaftsstandort
- Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung
- Christian Doppler Forschungsgesellschaft
Zitieren
APA
Hofer, B. S., Simbrunner, B., Königshofer, P., Brusilovskaya, K., Petrenko, O., Taru, V., Sorz-Nechay, T., Zinober, K., Regnat, K., Semmler, G., Lackner, C., Trauner, M., Mandorfer, M., Schwabl, P., & Reiberger, T. (2025). Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12643
Vancouver
Hofer BS, Simbrunner B, Königshofer P, Brusilovskaya K, Petrenko O, Taru V, et al. Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.12643
BibTeX
@article{Hofer2025,
author = {Hofer, Benedikt Silvester and Simbrunner, Benedikt and Königshofer, Philipp and Brusilovskaya, Ksenia and Petrenko, Oleksandr and Taru, Vlad and Sorz-Nechay, Thomas and Zinober, Kerstin and Regnat, Katharina and Semmler, Georg and Lackner, Carolin and Trauner, Michael and Mandorfer, Mattias and Schwabl, Philipp and Reiberger, Thomas},
title = {Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosis},
journal = {United European Gastroenterology Journal},
year = {2025},
doi = {10.1002/ueg2.12643}
}
EUVIMED